Market Access

There are a number of key elements in the preparation to launch a new therapeutic intervention into any market. Recent developments in the well established markets of Europe, North America and Australasia are increasing the burden on companies to not only understand the existing market in terms of customer needs but also predict some of the changes that will occur by the time they bring their product to the market.

Using the Patients Direct methodology, you can gain access to groups of patients and obtain a greater understanding of the medical condition, the unmet needs of patients and desires for future treatments. More specifically we can recruit patients on any product and this allows a greater insight into competitors’ offerings strengths and weaknesses as seen directly by the patient.

Whilst pricing, reimbursement and formulary acceptance is the main focus for market access professionals, many other considerations feed into the product assessment and positioning such as:

· Defining the treatment pathway in that country – are the patients managed in primary care or referred to specialists or hospital?

· Is the treatment pathway set out in guidelines and how does real life compare to the guideline?

· Existing therapeutic options and usual practice in that country/ market

· Are screening tools available readily?

· How do patients rate existing treatments and what are the unmet needs?

· What are the patients experiences of the whole service and treatment?

· What are the patients views on the factors that differentiate your treatment?

Patients Direct can gather the information required to identify your product positioning and value added proposition alongside the information required for a successful health economic case.